EcoDrugPlus

Tubulin Beta Chain-Like

Ensembl ID : ENSPREG00000007438
Gene Symbol: LOC103472951
2 Cross references
89 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSPREG00000005152
Gene Symbol: LOC103479562
3 Cross references
305 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPREG00000013315
Gene Symbol: TP53
2 Cross references
232 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPREG00000019772
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPREG00000013054
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPREG00000020052
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSPREG00000006784
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSPREG00000021138
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Fyn

Ensembl ID : ENSPREG00000020673
Gene Symbol: LOC103458010
4 Cross references
196 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSPREG00000001001
Gene Symbol: LOC103478918
3 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSPREG00000014312
Gene Symbol: LOC103479892
2 Cross references
206 Possible Orthologues:

Tyrosine-Protein Kinase Fyna-Like

Ensembl ID : ENSPREG00000006673
Gene Symbol: LOC103458742
3 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).